Home> Products> alpha 1 adrenergic agonist therapy

{ "products": [ { "_id": "68b0285a8456f6cd1a658352", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 5/10", "description": "ALFUGEM T 5/10 is a uniquely formulated combination of Alfuzosin Hydrochloride ER and Tadalafil, created to manage two common male health concerns—benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). This dual-benefit tablet not only helps relieve urinary symptoms caused by an enlarged prostate but also enhances sexual performance by improving blood flow to penile tissues.\n\nAlfuzosin, an alpha-1 adrenergic blocker, works by relaxing the smooth muscles of the prostate and bladder neck, allowing for easier urine flow. On the other hand, Tadalafil, a PDE5 inhibitor, relaxes blood vessels and supports better erections during sexual activity. Together, they offer a holistic treatment option for men dealing with both prostate-related urinary difficulties and sexual health concerns.\n\nUses of ALFUGEM T 5/10\n\nBenign Prostatic Hyperplasia (BPH): Eases urinary issues such as weak stream, frequent urination, incomplete bladder emptying, and difficulty initiating urination.\n\nErectile Dysfunction (ED): Improves erectile quality and sexual satisfaction.\n\nDual Therapy: Provides relief for men suffering from both BPH and ED, minimizing the need for multiple medications.\n\nEnhanced Quality of Life: Restores comfort, confidence, and overall wellness by improving both urinary and sexual functions.\n\nSide Effects of ALFUGEM T 5/10\n\nLike most medications, ALFUGEM T 5/10 may cause side effects, usually mild and temporary as the body adapts to treatment.\n\nCommon side effects include:\n\nHeadache\n\nDizziness or lightheadedness\n\nNasal congestion\n\nBack pain\n\nFlushing\n\nLess common but serious side effects:\n\nSudden low blood pressure (hypotension)\n\nSevere dizziness or fainting\n\nProlonged, painful erections (priapism – requires urgent care)\n\nVision or hearing disturbances\n\nAllergic reactions (rash, itching, facial/lip/throat swelling)\n\nPrecautions Before Use\n\nHeart Problems: Patients with recent heart attack, stroke, or serious heart disease should only use under strict medical advice.\n\nBlood Pressure: May lower blood pressure—avoid combining with other strong antihypertensives unless prescribed.\n\nNitrate Warning: Must not be used with nitrate medications (for chest pain/angina) due to risk of severe hypotension.\n\nLiver or Kidney Impairment: Dose adjustments may be needed.\n\nAlertness: Can cause dizziness—avoid driving or operating heavy machinery until you know your body’s response.\n\nDrug Interactions\n\nALFUGEM T 5/10 may interact with other medicines:\n\nNitrates (Nitroglycerin, Isosorbide): Can lead to life-threatening hypotension.\n\nAntihypertensives: May intensify blood pressure-lowering effects.\n\nOther PDE5 inhibitors (Sildenafil, Vardenafil): Should not be combined.\n\nStrong CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir): May increase Alfuzosin or Tadalafil levels.\n\nAlcohol: Increases dizziness and risk of low blood pressure.\n\nConclusion\n\nALFUGEM T 5/10 (Alfuzosin Hydrochloride ER & Tadalafil Tablets) is a comprehensive dual-action therapy designed for men experiencing both urinary issues due to BPH and sexual challenges related to ED. By combining an effective alpha-blocker with a proven PDE5 inhibitor, it provides relief from urinary discomfort while restoring erectile performance and confidence.\n\nWith proper medical guidance, ALFUGEM T 5/10 can greatly improve overall quality of life, making it a reliable option for men seeking urological and sexual wellness in a single solution.", "price": 385.0, "discountamount": 115.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2167, "imageuri": "https://productimages.withfloats.com/actual/68b0285da77b30c98906ef23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0285da77b30c98906ef23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:58:50.008Z", "updatedon": "2025-08-28T09:58:50.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-5-10/2167", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Alfuzosin Hydrochloride ER & Tadalafil Tablets", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d2854c1970de3d96ebcd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 100", "description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.", "price": 525.0, "discountamount": 158.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination ensures", "improved quality", "medications supplements", "drugs interact", "mouth cough", "reduce dependency", "synthetic corticosteroid", "asthma attacks", "asthma exacerbations", "asthma symptoms", "persistent asthma", "vilanterol powder", "controls inflammation", "reduces inflammation", "vilanterol ketoconazole", "lungs vilanterol", "vilanterol 25 mcg", "essential component", "bronchodilating effect", "antiinflammatory strength", "herbal products", "healthcare provider", "tricyclic antidepressants", "corticosteroids concurrent", "blood raising", "bronchodilatory effect", "adrenal activity", "breastfeeding consult", "liver problems", "fluticatone vilo 100", "oral thrush", "rash itching", "experience mild", "generally welltolerated", "emphysema prevention", "wheezing coughing", "prescription medication", "airflow obstruction", "constriction making", "chest tightness", "wheezing shortness", "inhalation precautions", "rescue inhalers", "hospitalizations improvement", "prevent flareups", "improves breathing", "fluticasone furoate", "chronic bronchitis", "lung function", "relaxing muscles", "rescue inhaler inform", "adolescents fluticasone furoate", "manage chronic symptoms", "inhalation fluticasone furoate", "lung function improvement", "effective longterm control", "breathing fewer flareups", "inhalation longterm control", "relaxing airway muscles", "inhalation side effects", "longterm maintenance treatment", "provide longterm relief", "chronic respiratory care", "consistent symptom control", "amplify cardiovascular effects", "side effects diuretics", "strong cyp3a4 inhibitors", "side effects betablockers", "physician regular monitoring", "palpitations muscle cramps", "moderate side effects", "breathlessness maintenance treatment", "acute bronchospasm relief", "fastacting treatment choice" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2139, "imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:20:21.253Z", "updatedon": "2025-07-01T12:28:46.31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-100/2139", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "682b219a6e1fabb425afe806", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA T 8/5", "description": "SILODOSIA T 8/5 is a powerful combination medication designed for the effective management of Benign Prostatic Hyperplasia (BPH) and associated urinary symptoms in men. By combining Silodosin (8 mg), a selective alpha-1 blocker, with Tadalafil (5 mg), a phosphodiesterase type 5 inhibitor, this dual-therapy tablet improves urinary flow and relieves symptoms such as frequent urination, incomplete bladder emptying, and urgency. It also provides added benefits for patients with concurrent erectile dysfunction (ED), offering a holistic approach to men's urological and sexual health.\n\nKey Ingredients\nSilodosin 8 mg\nAn alpha-1 adrenergic receptor antagonist that helps relax the muscles in the prostate and bladder neck, easing the flow of urine.\n\nTadalafil 5 mg\nA PDE5 inhibitor that enhances blood flow to the pelvic region and is primarily used to treat erectile dysfunction. It also helps reduce urinary symptoms in men with BPH.\n\nKey Benefits\nProvides rapid relief from lower urinary tract symptoms (LUTS) associated with BPH\n\nImproves urine flow by relaxing smooth muscles in the prostate and bladder neck\n\nReduces the need for frequent nighttime urination (nocturia)\n\nEnhances sexual function in men with coexisting erectile dysfunction\n\nImproves quality of life and confidence by addressing both urological and sexual issues\n\nOnce-daily dosing for convenience and better compliance\n\nHow Does It Work?\nSilodosin works by selectively blocking alpha-1 adrenergic receptors in the smooth muscles of the prostate and bladder neck. This causes the muscles to relax, allowing urine to pass more easily and reducing symptoms like urgency, frequency, and weak stream.\n\nTadalafil inhibits the PDE5 enzyme, increasing levels of cyclic GMP, which leads to relaxation of smooth muscles and improved blood flow. In the prostate and bladder, this relaxation helps relieve BPH symptoms, while also enhancing erectile function in men.\n\nTogether, these ingredients provide a synergistic effect that improves both urinary and sexual health outcomes.\n\nDirections for Use\nTake one tablet once daily, preferably at the same time each day\n\nSwallow the tablet whole with a glass of water\n\nCan be taken with or without food\n\nDo not crush or chew the tablet\n\nFollow your physician’s advice regarding the duration of therapy\n\nDo not exceed the recommended dose\n\nSide Effects\nDizziness or light-headedness, especially when rising from a sitting or lying position\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nDiarrhea or digestive discomfort\n\nEjaculation disorders (e.g., retrograde ejaculation)\n\nFlushing or warmth in the face\n\nRarely, priapism (prolonged erection) may occur—seek immediate medical attention if this happens\n\nVisual disturbances or blurred vision (in rare cases)\n\nIf you experience any severe or persistent side effects, consult your doctor immediately.", "price": 475.0, "discountamount": 143.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet follow", "urgency frequency", "mens urological", "urinary symptoms", "doctor immediately", "rare cases", "blurred vision", "visual disturbances", "medical attention", "physicians advice", "day swallow", "daily preferably", "synergistic effect", "ingredients provide", "cyclic gmp", "reducing symptoms", "rapid relief", "pelvic region", "pde5 inhibitor", "holistic approach", "relieves symptoms", "tadalafil 5 mg", "effective management", "smooth muscles", "helps relax", "added benefits", "bladder neck", "relaxing smooth muscles", "bladder neck reduces", "bladder neck easing", "improved blood flow", "enhances blood flow", "relax allowing urine", "bph key benefits", "retrograde ejaculation flushing", "enhancing erectile function", "work silodosin works", "treat erectile dysfunction", "selective alpha1 blocker" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2121, "imageuri": "https://productimages.withfloats.com/actual/682b21a0841d4ed84394ee61.png", "tileimageuri": "https://productimages.withfloats.com/tile/682b21a0841d4ed84394ee61.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-19T12:18:34.175Z", "updatedon": "2025-05-19T12:19:25.517Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/silodosia-t-8-5/2121", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Silodosin 8mg, Tadalafil 5 mg", "category": "UROLOGYRANGE", "tags": [ "Can silodosin and tadalafil be taken together", "Silodosin uses", "tadalafil 5mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "686e5df44c01bda1661052f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 2.5/10", "description": "ALFUGEM T 2.5/10 is a scientifically formulated dual-action oral tablet that combines Alfuzosin 2.5 mg and Tadalafil 10 mg. This unique combination is primarily used for the treatment of benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) in men. By blending a selective alpha-blocker (Alfuzosin) with a phosphodiesterase-5 (PDE5) inhibitor (Tadalafil), ALFUGEM T 2.5/10 offers an effective solution for patients who suffer from both urological conditions.\n\nThe combination of alfuzosin and tadalafil has been shown to have an additive relaxant effect on human detrusor and prostatic tissues in vitro, enhancing urinary flow and improving sexual function.\n\nWhat is ALFUGEM T 2.5/10?\nALFUGEM T 2.5/10 is a fixed-dose combination tablet that contains two active ingredients:\n\nAlfuzosin (2.5 mg) – an alpha-1 adrenergic receptor blocker that relaxes the muscles in the prostate and bladder neck.\n\nTadalafil (10 mg) – a PDE5 inhibitor that increases blood flow to the penis and also helps relax the smooth muscles in the prostate and bladder.\n\nTogether, they help relieve lower urinary tract symptoms (LUTS) associated with BPH and improve erectile function in men.\n\nUses of ALFUGEM T 2.5/10:\nTreatment of Benign Prostatic Hyperplasia (BPH)\n\nRelief of lower urinary tract symptoms (LUTS) such as weak stream, urgency, and incomplete bladder emptying\n\nManagement of erectile dysfunction (ED) in men\n\nMay be beneficial for patients with both BPH and ED as a once-daily treatment\n\nHow Does ALFUGEM T 2.5/10 Work?\nAlfuzosin works by blocking alpha-1 receptors in the prostate and bladder, leading to relaxation of smooth muscle and improved urine flow.\n\nTadalafil enhances nitric oxide activity, leading to vasodilation in the penile tissues and also relaxes the lower urinary tract muscles.\n\nThe additive relaxant effect of this combination on the prostate and bladder tissues helps improve both urinary and sexual symptoms.\n\nSide Effects of ALFUGEM T 2.5/10:\nLike all medications, ALFUGEM T 2.5/10 may cause some side effects. Common side effects include:\n\nDizziness or lightheadedness\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nIndigestion\n\nFlushing\n\nLow blood pressure (hypotension) in some cases\n\nRare but serious side effects may include:\n\nFainting or severe dizziness\n\nPriapism (prolonged or painful erection)\n\nVision changes or sudden vision loss\n\nChest pain or irregular heartbeat\n\nPrecautions Before Using ALFUGEM T 2.5/10:\nConsult your doctor before use if you have a history of heart disease, liver/kidney problems, or hypotension.\n\nAvoid activities like driving or operating machinery if you feel dizzy after taking the tablet.\n\nDo not take with other PDE5 inhibitors or alpha-blockers unless prescribed.\n\nLimit alcohol intake, as it can increase the risk of dizziness or low blood pressure.\n\nNot recommended for use in women or children.\n\nDrug Interactions – What Drugs Interact with ALFUGEM T 2.5/10?\nCertain drugs may interact with ALFUGEM T 2.5/10 and affect its effectiveness or increase the risk of side effects:\n\nAvoid or use with caution:\n\nNitrates (e.g., nitroglycerin) – can cause dangerous drops in blood pressure\n\nOther alpha-blockers – increased risk of hypotension\n\nAntifungals (e.g., ketoconazole, itraconazole)\n\nHIV protease inhibitors (e.g., ritonavir)\n\nAntibiotics (e.g., erythromycin, clarithromycin)\n\nBlood pressure medications – may enhance hypotensive effect\n\nGrapefruit juice – can alter the drug metabolism\n\nAlways inform your doctor about all the medications and supplements you are taking.\n\nConclusion:\nALFUGEM T 2.5/10 offers a comprehensive dual-action approach to managing two common male conditions – BPH and ED. With the clinically proven benefits of alfuzosin and tadalafil, this medication not only improves urinary flow and relieves prostate-related discomfort but also enhances sexual performance. Its synergistic relaxant effect on the bladder, prostate, and penile tissues makes it an ideal solution for men looking for convenience, efficacy, and improved quality of life.\n\nAlways follow your healthcare provider’s instructions for safe and effective use.", "price": 310.0, "discountamount": 93.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2143, "imageuri": "https://productimages.withfloats.com/actual/686e5df9e9241987c803df61.png", "tileimageuri": "https://productimages.withfloats.com/tile/686e5df9e9241987c803df61.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-09T12:17:56.999Z", "updatedon": "2025-07-09T12:17:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-2-5-10/2143", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "alfuzosin and tadalafil", "category": "UROLOGYRANGE", "tags": [ "alfuzosin and tadalafil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d70eaf0c9d1aa0c2d3e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 200", "description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 years", "24 hours", "increased risk", "drugs interact", "antiviral medications", "recommended dose", "airways open", "reduce inflammation", "acute asthma", "asthma attacks", "severe asthma", "copd attacks", "inhaler consistently", "optimal results", "breathing comfort", "longacting bronchodilation", "antiinflammatory power", "inhaled corticosteroids", "vilanterol antifungal", "tricyclic antidepressants", "taking betablockers", "prescribed inform", "tuberculosis rinse", "headache hoarseness", "initial phase", "generally welltolerated", "fluticatone vilo 200", "exercise capacity", "emphysema reduces", "chronic bronchitis", "relaxing muscles", "rescue medicine", "vilanterol relaxes", "prevent symptoms", "specially formulated", "vilanterol 25 mcg", "vilanterol powder", "rare effects", "ketoconazole ritonavir", "healthcare provider", "therapy common", "potent corticosteroid", "fluticasone furoate", "side effects", "lung function", "vilanterol fluticasone furoate", "copd exacerbations improves", "inhalation fluticasone furoate", "lung function quality", "fixeddose inhalation powder", "increase corticosteroid levels", "fastacting inhaler inform", "combination inhalation therapy", "side effects consult", "frequent side effects", "inhalation longterm treatment", "healthcare providers guidance", "ritonavir itraconazole leading", "highly effective corticosteroid", "effective oncedaily treatment", "heart rhythm disturbances", "strong cyp3a4 inhibitors", "hypokalemia mao inhibitors", "atenolol propranolol diuretics", "breastfeeding drug interactions", "pregnant planning pregnancy", "avoid oral thrush", "sore throat cough", "adolescents maintenance treatment", "longterm maintenance treatment", "prescription combination medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2140, "imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:39:42.59Z", "updatedon": "2025-07-04T07:41:47.804Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6819e619af35b11ab7f87163", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BUDEPRESS FORTE 400 CAPSULES", "description": "BUDEPRESS FORTE 400 combines powerful inhalation therapy ingredients to manage asthma and chronic obstructive pulmonary disease (COPD). This medication contains Formoterol Fumarate (12 mcg) and Budesonide IP (400 mcg), working together to alleviate and prevent respiratory symptoms including wheezing, shortness of breath, chest constriction, and chronic coughing. It delivers both sustained control and quick symptom relief, enhancing lung function and life quality.\nActive Components:\nFormoterol Fumarate (12 mcg)\nA long-acting beta-2 adrenergic agonist (LABA) that delivers quick and extended bronchodilation by relaxing airway muscles. Effects begin within minutes and continue for up to 12 hours, making it excellent for ongoing therapy.\nBudesonide IP (400 mcg)\nA strong inhaled corticosteroid (ICS) that reduces lung inflammation, swelling, and mucus production—primary factors contributing to asthma and COPD symptoms.\nPrimary Advantages:\nCombination therapy featuring both bronchodilator and anti-inflammatory for comprehensive respiratory management.\nQuick relief from bronchial constriction and breathing difficulties.\nExtended symptom control lasting up to 12 hours with regular administration.\nReduces asthma attack frequency and COPD flare-up severity.\nEnhances respiratory function for easier, more comfortable breathing.\nRequires fewer daily doses compared to short-acting alternatives.\nAppropriate for moderate to severe respiratory conditions under medical guidance.\nMechanism of Action:\nBUDEPRESS FORTE 400 operates through complementary actions of its two key ingredients:\nFormoterol Fumarate eases bronchial tube smooth muscles, creating airway expansion and rapid relief from narrowing that causes breathing distress.\nBudesonide, as an anti-inflammatory steroid, addresses underlying airway inflammation causing chronic symptoms and exacerbations. It diminishes hyperresponsiveness and mucus accumulation with consistent use.\nTogether, they prevent airway tightening, decrease inflammation, and facilitate smooth airflow, offering better management of chronic respiratory conditions.\nUsage Instructions:\nUse only as prescribed by your healthcare provider.\nTypically administered twice daily (morning and evening), though dosage may vary based on condition severity and individual response.\nShake inhaler thoroughly before each use.\nRinse mouth completely with water after each use to avoid oral thrush (fungal infection).\nNever exceed the prescribed dosage.\nFor effective management, maintain consistent use even when symptoms improve.\nPotential Side Effects:\nMost patients tolerate BUDEPRESS FORTE 400 well, though side effects may occur:\nCommon Effects:\n\nVoice changes or hoarseness\nDry mouth or throat irritation\nCoughing or throat discomfort\nHeadache\nMild trembling or shakiness\nElevated heart rate (palpitations)\n\nLess Common but Serious Effects:\n\nOral or throat fungal infection (thrush)\nAllergic responses (rash, swelling, breathing difficulty)\nMuscle cramping\nChest discomfort\nWorsening respiratory issues (paradoxical bronchospasm)\n\nContact your physician immediately for persistent or severe side effects.\nImportant Precautions:\nNot for acute asthma attack treatment—always maintain a rescue inhaler for emergencies.\nInform your doctor about heart conditions, diabetes, thyroid disorders, or liver issues.\nAvoid exposure to contagious diseases (e.g., chickenpox, measles) while using corticosteroid therapy.\nPregnant or nursing women should consult healthcare providers before using.\nStore securely away from children.\nBUDEPRESS FORTE 400 provides a clinically validated, dual-action approach to respiratory comfort—combining immediate relief with long-term management. With proper medical supervision, it significantly improves daily activity levels and decreases respiratory symptom burden.", "price": 940.0, "discountamount": 282.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 hours", "prescribed dosage", "longterm management", "rapid relief", "12 hours making", "delivers quick", "manage asthma", "store securely", "nursing women", "chickenpox measles", "contagious diseases", "emergencies inform", "rescue inhaler", "physician immediately", "effects oral", "side effects", "condition severity", "vary based", "daily morning", "mucus accumulation", "diminishes hyperresponsiveness", "complementary actions", "shortacting alternatives", "extended bronchodilation", "sustained control", "wheezing shortness", "bronchial constriction", "chronic coughing", "respiratory comfortcombining", "throat irritation coughing", "breath chest constriction", "severe respiratory conditions", "prevent respiratory symptoms", "proper medical supervision", "consult healthcare providers", "corticosteroid therapy pregnant", "hoarseness dry mouth", "rinse mouth completely", "breathing distress budesonide", "medical guidance mechanism" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2101, "imageuri": "https://productimages.withfloats.com/actual/6819e61c974ab387c1d08df8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6819e61c974ab387c1d08df8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-06T10:36:09.795Z", "updatedon": "2025-05-06T10:36:09.795Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/budepress-forte-400-capsules/2101", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Formoterol Fumarate (12 mcg), Budesonide IP (400 mcg)", "category": "ASTHMARANGE", "tags": [ "Formoterol fumarate and budesonide powder for inhalation ip", "Formoterol fumarate and Budesonide powder for inhalation ip uses", "Formoterol fumarate and budesonide inhaler dosage", "Formoterol fumarate and Budesonide Powder for Inhalation IP 400" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66fd3cb2b934f41a349df7b8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Silodosin 8mg", "description": "SILDOSOLID 8 contains Silodosin 8mg, an effective medication primarily used to treat the symptoms of benign prostatic hyperplasia (BPH), a condition commonly seen in older men. It helps alleviate discomfort caused by an enlarged prostate, such as frequent or difficult urination. SILDOSOLID 8 provides relief by relaxing the muscles in the prostate and bladder, making urination easier and improving overall urinary flow.\n\n \n\nKey Ingredients:\n \n\nSilodosin 8mg: The active ingredient in SILDOSOLID 8, Silodosin, is a selective alpha-1 adrenergic receptor antagonist specifically designed to target urinary problems related to BPH.\n \n\nKey Benefits:\n \n\nImproves Urinary Flow: SILDOSOLID 8 helps ease urination by relaxing the muscles around the prostate and bladder.\nReduces Symptoms of BPH: It significantly reduces symptoms like frequent urination, the urgency to urinate, and difficulty in starting urination.\nTargeted Relief: The selective action of Silodosin ensures relief without causing significant blood pressure changes.\nMinimizes Night-time Urination: It helps reduce the need to wake up frequently at night to urinate, improving sleep quality.\n \n\nHow Does It Work?\n\nSilodosin, the active component of SILDOSOLID 8, works by blocking alpha-1 adrenergic receptors in the muscles of the prostate and bladder neck. This action leads to muscle relaxation, allowing for easier urine flow and reducing the symptoms of BPH. Silodosin’s selective targeting minimizes side effects related to blood pressure, providing a focused treatment for urinary issues.\n\n \n\nDirections for Use:\n \n\nTake one SILDOSOLID 8 tablet daily or as directed by your healthcare provider.\nSwallow the tablet whole with a glass of water, preferably with food to avoid stomach upset.\nDo not crush or chew the tablet as it may affect the release mechanism of the drug.\nFollow your doctor’s prescription strictly to achieve the best results.\n \n\nSide Effects:\n\nWhile SILDOSOLID 8 is generally well-tolerated, some individuals may experience side effects, including:\n\nDizziness or fainting due to a drop in blood pressure\nEjaculation problems (retrograde ejaculation)\nNasal congestion or runny nose\nDiarrhea or upset stomach\nHeadache", "price": 245.0, "discountamount": 73.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "older men", "runny nose", "bladder neck", "best results", "side effects", "Key Benefits", "Silodosin 8mg", "stomach upset", "sleep quality", "urinary issues", "Targeted Relief", "Key Ingredients", "Nasal congestion", "active component", "urinary problems", "selective action", "release mechanism", "focused treatment", "muscle relaxation", "active ingredient", "easier urine flow", "frequent urination", "difficult urination", "healthcare provider", "selective targeting", "Night-time Urination", "Ejaculation problems", "effective medication", "overall urinary flow", "retrograde ejaculation", "one SILDOSOLID 8 tablet", "benign prostatic hyperplasia", "alpha-1 adrenergic receptors", "significant blood pressure changes", "selective alpha-1 adrenergic receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1983, "imageuri": "https://productimages.withfloats.com/actual/66fd3cb67d644ea46d659875.png", "tileimageuri": "https://productimages.withfloats.com/tile/66fd3cb67d644ea46d659875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-02T12:29:38.702Z", "updatedon": "2024-10-02T12:29:38.702Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/silodosin-8mg/1983", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Silodosin 8mg", "category": "UROLOGYRANGE", "tags": [ "Sildoo D 8 Uses in Hindi", "Sildoo D8 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }